Skip to main content

Advertisement

Log in

Lack of private financing hobbles emerging biotech regions

  • News
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

The availability of private funding remains an important but elusive factor for success

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Related links

Related links

Related links in Nature Research

https://doi.org/10.1038/News@Nature(10Aug2004)Bioentrepreneurship

https://doi.org/10.1038/NatureBiotechnology22,1060-1060(01Sep2004)News

Russia becomes attractive as a source of IP for biotechs

https://doi.org/10.1038/News@Nature(06Oct2005)Bioentrepreneurship

https://doi.org/10.1038/NatureBiotechnology23,1031-1031(01Sep2005)News

Materials exchange deal meager boost to India's biotech

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jia, H., Jayarama, K. & Astvatsaturyan, M. Lack of private financing hobbles emerging biotech regions. Nat Biotechnol 24, 7–9 (2006). https://doi.org/10.1038/nbt0106-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0106-7

  • Springer Nature America, Inc.

This article is cited by

Navigation